Skip to main content
logo
Ananda Pharma Plc (AQU:ANA)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.3050
0.00 (0.00%)
At close: Jul 16, 2025

Ananda Pharma Cash Flow Statement

Millions GBP. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jul '24 Jan '24 Jan '23 Jan '22 Jan '21 Jan '20 2019
Net Income
--6.15-1.3---0.37
Upgrade
Depreciation & Amortization
-0.560.17---
Upgrade
Asset Writedown & Restructuring Costs
-4.550.04---
Upgrade
Stock-Based Compensation
-0.020.01---
Upgrade
Other Operating Activities
--0.790.42--0.01
Upgrade
Change in Accounts Receivable
-0.14-0.14---0.32
Upgrade
Change in Accounts Payable
-0.950.34--0.17
Upgrade
Operating Cash Flow
--0.72-0.46---0.51
Upgrade
Capital Expenditures
--0----
Upgrade
Cash Acquisitions
-0.020.03---
Upgrade
Investment in Securities
---1.48---
Upgrade
Other Investing Activities
-0----
Upgrade
Investing Cash Flow
-0.02-1.45---
Upgrade
Long-Term Debt Issued
-0.31.89---
Upgrade
Long-Term Debt Repaid
---0.04---
Upgrade
Net Debt Issued (Repaid)
-0.31.85---
Upgrade
Issuance of Common Stock
-0.470.07--0.4
Upgrade
Financing Cash Flow
-0.771.92--0.4
Upgrade
Net Cash Flow
-0.070.02---0.11
Upgrade
Free Cash Flow
--0.72-0.46---0.51
Upgrade
Free Cash Flow Per Share
---0.00---0.00
Upgrade
Levered Free Cash Flow
--0.94-0.41---0.02
Upgrade
Unlevered Free Cash Flow
--0.85-0.25---0.02
Upgrade
Change in Net Working Capital
-1.45-0.43-0.19-0.2-0.12-0.22
Upgrade
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.